Events, news and blogposts at CEMIR
Tuberculosis kills about 1,5 million people each year and about 1/3 of the world's population is infected. Trude Flo and her research group at NTNU studies the interactions between the bacteria that cause tuberculosis and the immune system of the host. Understanding these interactions is crucial for the development of new vaccines and medicines to treat tuberculosis. (YouTube)
- Professor får pris for forskning på betennelser, forskning.no (Norwegian)
- Pris for betennelsesforskning, Gemini 27.11.2017 (Norwegian)
- Norwegian research achievement: The immune system can kill, TV2, 13.11.2017 (Norwegian)
- How tuberculosis hides in the body, Gemini 28.09. 2017
- Understanding how omega-3 dampens inflammatory reactions, Gemini 22.08. 2017
- How plague attacks us – and how we can defend ourselves, Gemini 12.06. 2017
- Omega-3 reduce the risk of diseases, forskning.no (Norwegian)
- So essential is the good cholesterol, forskning.no (Norwegian)
- Uncovering the secrets of inflammation, Gemini
- How Kristian would solve the Black Death mystery, Dagbladet (Norwegian)
- The molecule that stops the Black Death, ScienceNordic
- The Black Death bacterium save lives, NRK, Schrödingers Katt (Norwegian)
- What is a vaccine? NRK, Newton (Norwegian)
Annual Report 2016 from CEMIR
The scientific activities at our centre have proceeded with very good progress since we started in 2013. In 2016 we published 61 papers in peer reviewed journals. CEMIR researchers have published more than 200 articles since 2013, several in high quality journals like Nature, Nature Immunology, Autophagy, PNAS and J Immunol. Seventeen PhD students have completed their theses at the centre since 2013.
An important event to highlight from 2016 is the international conference hosted by CEMIR in Trondheim: Conference on Molecular Mechanisms of Inflammation. 200 participants from 20 different countries and 25 invited speakers made this conference an important arena to foster further innovative research on molecular mechanisms and regulation of inflammation.
CEMIR is approaching the end of the first five-year period as a Centre of Excellence (CoE). All CoEs will be midterm evaluated in 2017, and based on the evaluation the Research Council will decide whether the centre will receive financing for the second five-year period. The annual report is part of the background material for the evaluation committee.
CEMIR is proud to present the latest annual report, summing up our most important scientific achievements from the first centre period. Read more about our results and scientific highlights in the annual report.
CEMIR Annual Report 2016 [pdf]More about CEMIR and our Annual reports